RecruitingNCT05172089

Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence


Sponsor

University of Pittsburgh

Enrollment

405 participants

Start Date

Apr 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This work is based on DFU patients, seeks to conduct a fully powered clinical study testing i) If DFU with a history of biofilm infection closes with deficient barrier function. ii) whether such functionally deficient wound closure, manifested as high TEWL, is associated with greater wound recurrence. The primary parent study will also address molecular mechanisms implicated in biofilm-induced loss of skin epithelial barrier integrity in DFU patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with biofilm infection, chronic wounds, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

University of Arizona

Tucson, Arizona, United States

UPMC Wound Healing Services at UPMC Passavant

Cranberry Township, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05172089


Related Trials